Skip to content

Author

Thomas Spangenberg

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Modeling the potential effect of cabamiquine-pyronaridine for chemoprevention against Plasmodium falciparum malaria

ABSTRACT Preventive treatment (chemoprevention) is a key intervention for reducing the burden of Plasmodium falciparum malaria in children. The impact of the current widely used drug combination, sulfadoxine-pyrimethamine-amodiaquine (SP-AQ), is challenged by emerging drug resistance and adherence to multi-day dosing....

Lucy C. Okell, Perrine Courlet, F. Venezia et al. · 0 citations
#protein folding Open access Sep 2026

In vitro pharmacodynamics of the antimalarial drug cabamiquine

In vitro findings help contextualize why the clinically observed lag in parasite clearance may be temporally distinct from symptomatic improvement, including fever resolution, and present cabamiquine as a fast-acting, slow clearing antimalarial drug.

Claudia Demarta-Gatsi, J. Wallner, S. K. Dhingra et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.